ReviewTheranostic Advances in Vascular Malformations
Under an Elsevier user license
open archive
Abbreviations
AE
adverse event
AKT
protein kinase B
AVM
arteriovenous malformation
CM
capillary malformation
EC
endothelial cell
ERK
extracellular signal–regulated kinase
HHT
hereditary hemorrhagic telangiectasia
LM
lymphatic malformation
MAPK
mitogen-activated protein kinase
MEK
MAPK/ERK kinase
mTOR
mammalian target of rapamycin
PI3K
phosphatidylinositol-3-kinase
PROS
PIK3CA-related overgrowth spectrum
VM
venous malformation
Cited by (0)
© 2019 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.